RE:RE:RE:RE:RE:RE:Let’s look at the forest, not the trees145,
Your scenario is interesting, but from what i read is; that negociations with ALSTOM are jammed for a matter of valuation coming from the legacy projecys. I assume CDPQ would have the same dilemnia with valuation and risks associated with the legacy projects,